Glimepiride (2mg) + Metformin (500mg)
Switglim-M 2/500 Tablet PR is used in the treatment of type 2 diabetes.
1 Strip of 10 Tablet
Akumentis Healthcare Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Use it as advised by your doctor or check the label for directions before use. Switglim-M 2/500 Tablet PR is to be taken with food.
Switglim-M 2/500 Tablet PR may cause stomach upset if taken empty stomach.
Switglim-M 2/500 Tablet PR is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body"s sensitivity to insulin.
Related Warnings
Taking metformin with alcohol can cause lactic acidosis and you may experience malaise, respiratory distress, slow or irregular heartbeat, sleepiness, stomach upset, or other unusual symptoms.
Switglim-M 2/500 Tablet PR may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Switglim-M 2/500 Tablet PR is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
Switglim-M 2/500 Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Switglim-M 2/500 Tablet PR may be needed. Please consult your doctor.
Use of Switglim-M 2/500 Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Switglim-M 2/500 Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Switglim-M 2/500 Tablet PR may be needed. Please consult your doctor.
Switglim-M 2/500 Tablet PR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
